Search Orphan Drug Designations and Approvals
-
Generic Name: | Dextran 70 |
---|---|
Date Designated: | 03/05/1990 |
Orphan Designation: | Treatment of recurrent corneal erosion unresponsive to conventional therapy. |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Holles Laboratories, Inc. 30 Forest Notch Cohasset, Massachusetts 02025 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-